NCT00818844View on ClinicalTrials.gov

Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Epiretinal Membrane
Interventions
DRUG

Nepafenac 0.1%

NSAID

OTHER

BSS

BSS

Trial Locations (1)

45242

Dan Miller, Cincinnati

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00818844 - Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery | Biotech Hunter | Biotech Hunter